Verisk Analytics Releases Q2 2026 Financial Results

Verisk Analytics reported Q2 2026 diluted adjusted EPS of $1.98, slightly above the $1.97 consensus, and revenue of $806.3M, up 4.3% from Q2 2025. Adjusted net income was $259.3M. For FY 2026, it guided adjusted EPS of $7.45 to $7.75 and revenue of $3.19B to $3.24B.

Original reporting
Published Jul 29, 2026, 1:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 5:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Verisk Analytics Releases Q2 2026 Financial Results — source image
Decision brief

The 30-second read

$VRSKBullishMed
01

Why it matters

The disclosed EPS and revenue beat, plus FY 2026 adjusted EPS and revenue ranges, provide fresh inputs for earnings model updates and near-term positioning.

02

Market read

Traders can update expectations for FY 2026 earnings power based on the provided guidance ranges and the reported beat versus consensus.

03

What to watch

The article does not break out margin, cash flow, or segment-level organic drivers beyond underwriting, which can be key for valuation and forward estimates.

Relevance 8/10Novelty 7/10Timing: post-release, ahead of next earnings/analyst revisions cycle

Background

Verisk is a data analytics and risk assessment provider serving insurance and energy verticals; this is a quarterly earnings and guidance update.

Company-level read

Ticker impact

$VRSKBullishMedium confidence
Context

Verisk reported Q2 2026 diluted adjusted EPS of $1.98 and revenue of $806.3M, beating consensus and updating FY 2026 guidance.

Expected impact

Near-term bias upward versus expectations, assuming the market focuses on the EPS and revenue guidance range.

Evidence & confidence

The article provides specific beat metrics and a concrete FY 2026 adjusted EPS and revenue outlook, which typically drives post-earnings repricing and forward multiple expectations.

Market effects

Reinforces demand durability for insurance data and risk analytics spend, a read-across for insurtech and analytics peers.

Primarily US large-cap sentiment for business analytics and insurance software/data names.

Limited direct global spillover beyond insurance analytics demand signals.

Counterpoint

The beat is modest (0.5% over consensus) and organic growth is only mid-single digits, so upside may be capped if investors expected acceleration.

Key entities

  • Verisk Analytics, Inc.

    Reported Q2 2026 adjusted EPS and revenue, and provided FY 2026 guidance.

Related articles

$VRSKMedAI 8/10

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Verisk Analytics (NASDAQ:VRSK) reported Q2 2026 revenue of $806 million, up 4.3% reported and 5.8% organic constant currency. Adjusted EBITDA was $464 million, up 7.4% on the same basis. Subscription revenue was 83% of total, and diluted adjusted EPS was $1.98. Full-year guidance was reaffirmed: revenue $3.19B to $3.24B and EPS $7.45 to $7.75.

$VRSKMedAI 8/10

Verisk Ordered to Move Ahead With $2.35 Billion AccuLynx Merger

A Delaware Chancery Court judge ordered Verisk Analytics to proceed with its $2.35 billion merger with AccuLynx, rejecting AccuLynx’s bid to raise the deal price over antitrust clearance concerns. The judge cited willful conduct by AccuLynx for a failed closing condition and awarded AccuLynx damages for direct costs plus interest. The deal still requires HSR Act clearance and FTC approval.

$VRSKMedAI 8/10

[VRSK Q2 2026 Earnings Call] Verisk Q2 Organic Revenue Hits 5.8% as XactAI Users Jump 10x to 7,000, but Transactional Drag Persists — BigGo Finance

Verisk Analytics (VRSK) reported Q2 2026 revenue of $806 million, up 5.8% organic constant currency, driven by 8% subscription growth (83% of revenue). Transactional revenue fell 4.2% due to softer commercial property quotes and weaker weather demand. XactAI users rose 10x to 7,000. Full-year guidance of $3.19–$3.24B revenue and $1.79–$1.83B adj. EBITDA was reaffirmed.

$VRSKMed

Verisk Vaults on Releasing Q2 Results

Verisk (NASDAQ: VRSK) reported Q2 results for the quarter ended June 30, 2026. Net income fell 9.8% to $229 million, citing higher tax rate, net interest expense, and legal fees tied to litigation. The company paid a $0.50 dividend per share and launched a $200 million accelerated share repurchase, with an initial delivery of 949,190 shares at $179.10. Shares rose 9.6% to $221.87.